Attached files
| file | filename |
|---|---|
| EX-14.1 - CODE OF ETHICS - GT Biopharma, Inc. | ex141.htm |
| EXCEL - IDEA: XBRL DOCUMENT - GT Biopharma, Inc. | Financial_Report.xls |
| 10-K - OXIS INTERNATIONAL, INC. ANNUAL REPORT 2012 - GT Biopharma, Inc. | oxis10k2012.htm |
| EX-32.1 - CERTIFICATION SECTION 906 - GT Biopharma, Inc. | ex321.htm |
| EX-31.2 - CERTIFICATION SECTION 302 - GT Biopharma, Inc. | ex312.htm |
| EX-32.2 - CERTIFICATION SECTION 906 - GT Biopharma, Inc. | ex322.htm |
| EX-31.1 - CERTIFICATION SECTION 302 - GT Biopharma, Inc. | ex311.htm |
Exhibit 21.1
SUBSIDIARIES OF OXIS INTERNATIONAL, INC.
As of December 31, 2012, the Company’s subsidiaries were as follows:
|
Name
|
Jurisdiction of incorporation
|
|
|
OXIS Therapeutics, Inc.
|
Delaware
|
|
|
OXIS Isle of Man Limited
|
Isle of Man
|
|
|
Oxis Consumer Products, LLC
|
Delaware
|